2 Followers USX:GRTS - Gritstone bio Inc Gritstone bio Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 11 Mar 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 13.2    +2.700 (+25.71%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

30 Nov 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.

IPO: 2018-09-28

Headquarters: US

Employees: 188

Homepage

Description

Gritstone Bio Inc is a United States-based biotechnology company. It is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.